Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
Abroad (travel likely)RecruitingPHASE2
Conditions
Breast Cancer · Metastatic Breast Cancer · Advanced Breast Cancer · Hormone-receptor-positive Breast Cancer · Human Epidermal Growth Factor 2 Low Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States
Contact: Study coordinator (Krystal Fernandez) · krystal.fernandez@baptisthealth.net · (786) 596-2000Winship Cancer Institute at Emory University, Atlanta, Georgia, United States
Study leads
Reshma L Mahtani, D.O.
Principal Investigator
Miami Cancer Institute at Baptist Health, Inc.